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TO THE EDITOR
Androgenetic alopecia (AGA) is the
most common form of human baldness
mediated by androgens. As most of the
patients show normal levels of circula-
ting androgens, a local in situ over-
production or/and androgen hyper-
response of the skin are suggested and
supported by many studies, whereas
higher levels of type I and type II 5a-
reductase isozymes and androgen re-
ceptors have been demonstrated in
frontal hair follicles than in occipital
follicles (Hibberts et al., 1998; Hoff-
mann, 2003). It remains unclear, how-
ever, whether the locally overproduced
testosterone and 5a-dihydrotestosterone
in the bald scalp derive from the
cutaneous de novo androgen synthesis
from serum cholesterol or from a short-
cut, using serum dehydroepiandroster-
one. Both are abundant, especially
cholesterol. Four ‘‘upstream’’ enzymes
including steroidogenic acute regula-
tory protein (StAR), cytochrome
P450 cholesterol side-chain cleavage
enzyme (P450scc) and cytochrome
P450 17a-hydroxylase/17,20-lyase
(P450c17), and steroid 3b-hydroxyster-
oid dehydrogenase (3b-HSD) are re-
sponsible for the early steps of
androgenesis from cholesterol to dehy-
droepiandrosterone. StAR regulates the
first committed rate-limiting step by
controlling the delivery of cholesterol
from the outer membrane to the inner
membrane of mitochondria, where
cholesterol is further converted to preg-
nenolone by P450scc complex (Miller,
2002). Pregnenolone undergoes 17a-
hydroxylation by microsomal P450c17
to form 17-hydroxypregnenolone and
then is transformed to dehydroepian-
drosterone by the 17,20-lyase activity
of P450c17. Dehydroepiandrosterone
is then converted by 3b-HSD to
androstenedione, the substrate for tes-
tosterone.
We studied regional differences of
the bald frontal–parietal versus the
occipital scalp in the gene expression
of the foregoing four enzymes in male
AGA by using a quantitative, competi-
tive RT-PCR method (Tsai and Wilt-
bank, 1996) (Figure 1a and b). Totally,
51 male AGA patients at stages III–VII
according to the modified Norwood/
Hamilton classification were recruited,
with 25 patients (mean age 34.9 years,
range 24–52 years) free of medication
and 26 patients (mean age 37.3 years,
range 21–58 years) taking 1 mg finaster-
ide daily for at least 3 months. The
study was conducted according to the
Declaration of Helsinki Principles and
approved by the Medical Ethical Com-
mittee of the Chang Gung Memorial
Hospital, with written informed consent
given by the participants. Paired data
from both areas were obtained from 48,
46, and 20 of the total 51 patients for
StAR, 3b-HSD, and P450scc, respec-
tively. The estimated amount of the
mRNA of each gene in the bald scalp,
as normalized to the expression level of
glyceraldehyde 3-phosphate dehydro-
genase, was most abundant for StAR,
followed by 3b-HSD, and much less for
P450scc and P450c17. In 19 patients
with detectable P450c17 mRNA, 10
had only expression in the bald scalp,
whereas three only in the occipital
scalp, and six had paired data from
both areas. DNA sequencing of the PCR
amplification of 3b-HSD (Tsai et al.,
2001) confirmed the gene expression of
type I instead of type II 3b-HSD in the
skin, even in the bald scalp (Dumont,
1992).
When the mRNA expression in the
occipital (H) scalp was taken as 1,
significantly higher levels of StAR and
3b-HSD were demonstrated in the bald
parieto-frontal (B) scalp as compared to
the occipital scalp, represented by ele-
vated B/H ratio (P¼0.0117 and 0.0164,
respectively, paired t-test) (Figure 1c
and d). No regional difference existed
regarding P450scc (P¼ 0.3752). The
regional difference of the examined
genes was not consistent among the
examinee, that is, some AGA patients
with overexpression of StAR in their
bald scalps showed normal or lower
levels of 3b-HSD in the same area, and
vice versa. No association existed
between the expressional intensity of
StAR, 3b-HSD, or P450scc and the
baldness severity (Pearson’s product-
moment correlation test) or between
them and the patients’ age (multiple
linear regression). Correlation among
the four examined genes with each
other was insignificant (analysis of
variance test). There was no difference
between the finasteride treatment and
non-treatment group regarding the
regional expressional intensity (B/H) of
each examined gene (paired t-test). All
the statistics and analysis were per-
formed using SAS PC software (version
9.1; SAS, Cary, NC).
Immunocytochemistry performed on
cultured SZ95 sebocytes showed loca-
lization of StAR mainly in the peri-
nuclear portion of the cytoplasma
(Figure 2a). The smaller rather undiffer-
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Figure 1. Detection and quantification of mRNA. After preparation and construction of the native and competitive plasmids for in vitro transcription of
respective RNAs, the standard curves of quantitative competitive RT-PCR for each measured genes including (a) StAR and (b) type I 3b-HSD1 were generated
by analyzing the intensity of bands derived from ethidium bromide-stained PCR products. A 2-fold serial dilution of native RNA was reverse transcribed
and PCR amplified in the presence of 1 aM competitor. The band intensity was quantified by AlphaImager computer software. Representative gel picture
showing PCR products amplified from paired specimens taken from the bald fronto-parietal (B) and hairy occipital (H) scalps of men with AGA during hair
transplantation. After calibration by the expressional intensity of glyceraldehyde 3-phosphate dehydrogenase (GAPDH), a B/H ratio for the measured mRNA
levels was obtained from each individual subject regarding (c) StAR and (d) 3b-HSD1, respectively. Mean value of B/H ratio was calculated for StAR and
3b-HSD1 from 48 and 46 patients, respectively. As compared with the enzyme expression in the occipital scalp (H, taken as 1), significantly higher levels
of StAR and 3b-HSD1 were found in the bald fronto-parietal scalp (Po0.05). NC, negative control by omitting reverse transcriptase during the RT procedure.
*
*
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Figure 2. Immunodetection of StAR in vitro and in vivo. A specific rabbit polyclonal antibody raised against amino acids 1–285 representing full-length
StAR of human origin (Santa Cruz, Santa Cruz, CA) was used and diluted to 1:100 and 1:50 in diluent (DAKO, Glostrup, Denmark) for cultured cells and
for skin derived from vertical scalp of a 24-year-old man without AGA, respectively. StAR was detected mainly in (a) the perinuclear cytoplasm of the cultured
SZ95 sebocytes, (b) basal layer of the sebaceous glands, (c) epidermal keratinocytes, (d) outer root sheath of hair follicles (asterisk), (e) vascular tissues
(arrowhead), and (f) eccrine sweat ducts (arrow) but not eccrine sweat glands. Note the stronger expression of StAR protein in the small undifferentiated
sebocytes (a and b). Bar¼ 20 mm.
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entiated sebocytes displayed more
strongly the StAR protein. Immunohisto-
chemistry showed strong expression of
StAR in the basal layer of sebaceous
glands (Figure 2b), epidermal keratino-
cytes (Figure 2c), outer root sheath of
hair follicles (Figure 2d) but not dermal
papilla cells (data not shown), vascular
tissues (Figure 2e), and eccrine sweat
ducts but not eccrine sweat glands
(Figure 2f). It is noteworthy that in hair
follicles, androgen receptor expression
was demonstrated to be restricted to
dermal papilla cells, whereas in sebac-
eous glands, it was observed by some
authors to predominate in the basal
sebocytes but by others to exist both in
basal cells and differentiating sebocytes
(Thornton et al., 2003; Pelletier and
Ren, 2004). Our finding of a stronger
expression of StAR protein in the
undifferentiated sebocytes seems to be
in line with the observation that andro-
gens stimulate the proliferation of hu-
man sebocytes (Zouboulis et al., 1999),
contrary to the data from rat preputial
sebocyte model, which postulated the
major effect of androgens was on an
early step in cell differentiation (Miyake
et al., 1994; Rosenfield et al., 1999).
In steroidogenic cells, tropic hor-
mones can regulate the StAR protein
expression by cAMP-dependent me-
chanisms (Manna et al., 2003). A recent
study showed that prostaglandin E2-
stimulated StAR gene activation is
mediated by E prostanoid receptor
2-coupled cAMP–protein kinase A path-
way in peripheral endocrine tissues
(Sun et al., 2003). cAMP is also
required for the growth and differentia-
tion of rat preputial sebocytes (Rosen-
field et al., 2002). These data including
our own seem to suggest the close
interaction between androgenesis and
prostaglandins in regulation of the
sebocyte development (Zouboulis,
2005).
Upregulation of StAR and 3b-HSD in
the bald scalp of AGA patients may
simply reflect marked hyperplasia of
sebaceous glands contrasted with the
miniaturized hair follicles or imply the
active de novo biosynthesis of andro-
gens in pilosebaceous units. Given
the juxtaposition of hair follicle and
sebaceous glands, a kind of paracrine
effect originating from sebaceous
gland-secreted androgens on the
growth and development of hair folli-
cles is possible. Separate isolation of
sebaceous glands and hair follicles to
determine the difference of gene ex-
pression in bald and hairy scalp would
help clarify the contributory role of
each steroidogenic organ.
The significance of high StAR levels
but limited gene expression of P450scc
and P450c17 in the skin as well as in
most other steroidogenic tissues is not
clear (Slominski et al., 1996; Thiboutot
et al., 2003). As StAR is an acutely
regulated protein with very short half-
life, its regulation at the transcriptional
level may be required in order to
provide sufficient mRNA transcripts for
synthesizing protein that carries choles-
terol to the inner mitochondria. On the
other hand, the P450c17 expression in
diseased state may be different, as
P450c17 mRNA was more commonly
detected in the bald than occipital areas
of our AGA patients.
Enhanced expression of StAR and
3b-HSD in the bald area further implies
that locally aberrant production of
androgens may play a significant role
in the development of the disease.
Comparable data from normal controls
without AGA including functional stu-
dies on the enzyme activities are
needed to determine the role of de
novo androgenesis in the pathogenesis
of AGA.
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TO THE EDITOR
It has been suggested that psoriasis
vulgaris (PV) is a multifactorial disease
and that environmental factors may
trigger PV in genetically susceptible
individuals (Elder et al., 2001; Lebwohl,
2003). At the PSORS1 locus on chromo-
some 6p21.3, the human leukocyte
antigen (HLA)-Cw*0602 allele strongly
associates to susceptibility to psoriasis
in various populations (Mallon et al.,
1999; Zhang et al., 2002). Aside from
HLA-C, the implication of natural killer
and natural killer-T (NK/NKT) cells in
PV and psoriatic arthritis (PA) has also
drawn much attention recently (Martin
et al., 2002; Holm et al., 2005). NK/
NKT cells were present in chronic
psoriatic plaques and the NK/NKT cell
line was shown to induce psoriasis in a
severe combined immunodeficient
mouse model (Nickoloff et al., 2000).
NK/NKT cell function is regulated by
activating and inhibitory receptors pre-
sent on the cell surface. Among them,
the killer cell immunoglobulin-like re-
ceptor (KIR) is the major molecule
recognizing HLA-C and is encoded by
the KIR gene family clustered on
chromosome 19q13.4. KIRs include
activating KIRs such as KIR2DS and
inhibitory KIRs such as KIR2DL.
KIR2DS1 can recognize group 2 HLA-
C including HLA-Cw2, -Cw4, -Cw5,
-Cw6, and related alleles which carry
lysine at amino acid 80 (Lys80). On the
other hand, KIR2DS2 can recognize
group 1 HLA-C such as HLA-Cw1,
-Cw3, -Cw7, –Cw8, and related alleles
which carry Asn80. KIR2DS1,
KIR2DS2, and KIR2DL5 have been
associated with PA and PV (Luszczek
et al., 2004; Suzuki et al., 2004;
Williams et al., 2005). Furthermore,
subjects who are homozygous for
HLA-Cw group 1 or 2 and positive for
KIR2DS1 and/or KIR2DS2 are found to
be most susceptible to developing PA
(Nelson et al., 2004), and patients with
guttate psoriasis were associated with a
distinct HLA-C/KIR genotype profile
(Holm et al., 2005).
In this study, we investigated the
association of the KIR genes (KIR2DS1,
KIR2DS2, KIR2DL1, KIR2DL2, and
KIR2DL5) with PV in 178 Chinese
patients with PV and 203 control
subjects in Taiwan. All participants
gave their written informed consent
before enrolling in the study. The study
was carried out with the approval of the
institutional review board of the hospi-
tal and conducted according to the
Declaration of Helsinki Principles. The
178 psoriasis patients included 125
males and 53 females with a mean
age of 55.9 years (range, 7–87 years);
the predominance of male PV patients
in Chinese has also been reported in a
previous study (Chen et al., 2003).
Ninety-two patients (51.7%) had an
onset of psoriasis before the age of
40 years (early-onset psoriasis) and 86
patients (48.3%) had an onset at age 40
years or older (late-onset psoriasis).
Sixteen (9%) of these patients reported
a family history of PV. The control
group comprised 203 healthy indivi-
duals (141 males and 62 females with a
mean age of 53.9 years (range, 18–77
years)) and included voluntary blood
donors, hospital staff, and medical
students. Genotyping for KIR2DS1,
KIR2DS2, KIR2DL1, KIR2DL2, and
KIR2DL5 was detected by PCR with
sequence-specific primers (Gomez-
Lozano and Vilches, 2002) with an inter-
nal positive control included in each
PCR reaction. Genotyping for HLA-
Cw*0602 was also carried out using
HLA Typing Kits (Lifecodes, Stamford,
CT) and confirmed by sequence-based
typing method (Chang et al., 2004). The
differences of the allele frequencies
between the case and control subjects
were assessed using w2 test or Fisher’s
exact test. Odds ratios, confidence
intervals, and significance values were
calculated using the Epi Info 2000
(CDC, Atlanta, GA).
As shown in Table 1, the genotype
frequencies of activating KIRs (KIR2DS1
and KIR2DS2) and inhibitory KIRs
(KIR2DL1, KIR2DL2, and KIR2DL5)
were similar between the PV patients
and the controls. Therefore, KIR2DS1, a
major susceptibility gene to PV found in
the Caucasian and Japanese popula-
tions, was not a risk gene in the Chinese
population; in fact, the KIR2DS1 fre-
quency in our PV patients was even
Abbreviations: HLA, human leukocyte antigen; KIR, killer cell immunoglobulin-like receptor;
PA, psoriatic arthritis; PV, psoriasis vulgaris
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